IL17A and rheumatoid arthritis: In this paper, we have shown that new-onset DMARD-naïve RA patients have abnormally functioning circulating CD4+T-lymphocytes with an expansion of the CD4+IL-17A+, CD4+IFNγ+ and CD4+IL-17A+IFNγ+T subsets.